ClinicaliQ Trial Snapshot
- International CRDS Registry — Recruiting • NCT06508164.
- A new registry tracks a rare genetic heart rhythm condition caused by RYR2 gene faults to understand its features and best treatments.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Calcium Release Deficiency Syndrome (CRDS) is a newly discovered genetic arrhythmia syndrome that confers a risk of life-threatening arrhythmias secondary to RYR2 loss-of-function. The International CRDS registry has been designed to facilitate large-scale evaluation of CRDS, including its phenotypic spectrum, approaches to risk stratification, and optimal treatment strategies. Conditions: Calcium Release Deficiency Syndrome Lead Sponsor: Population Health Research Institute Planned Enrollment: 500 participants